Moneycontrol PRO
HomeNewsTrendsHealthGovt asks syringe makers to put supplies on hold as demand for COVID-19 shots fall

Govt asks syringe makers to put supplies on hold as demand for COVID-19 shots fall

Last year, the government was struggling to procure 90 crore syringes, mainly needed for the national COVID-19 vaccination drive following which the crucial medical supply was included in the list of goods restricted for export

February 17, 2022 / 18:18 IST
Representational Image.
Source: Reuters

Representational Image. Source: Reuters

The Centre has put the supply of syringes used in COVID-19 vaccination and shots for the Universal Immunisation Programme on hold for two months, throwing over 15 suppliers who have been affected, in a tizzy.

The directive, according to sources, is a result of surplus inventories, storage space crisis and a dwindling need for syringes and needles as demand for the COVID vaccination ebbs in the country

Between July and October last year, the Health Ministry had placed orders for syringes, with an aim to target 2 billion COVID-19 vaccination shots by December 2021, which was later extended to March this year.

As the ministry was struggling to procure enough syringes, as per the required specifications, it had also put restrictions on the export of syringes—much to the discomfort of suppliers-- which was lifted only beginning this month.

Now the abrupt order dated February 14—issued by the Central Medical Service Society under the ministry which postpones procurement of over 24 crore syringes—has caught the manufacturers off guard who are perplexed at being asked to suspend production and supplies by 2 months.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Industry sources said that as 175 crore COVID-19 shots have already been administered in India, it has led to a reversal in situation-from crisis to abundant supply. So just two weeks after export restrictions were lifted, manufacturers are now being told to stop supplying to the government.

Suppliers are also not clear if this will have cascading effect and orders placed for April to July delivery will also be rescheduled by two months further or they will need to be supplied along with the rescheduled deliveries.

Rajiv Nath, president of the All-India Syringes & Needles Manufacturers Association and managing director of Hindustan Syringes and Medical Devices said that the syringe makers had been seeking lifting of the export restriction since December which was not done despite assurances by the ministry.

“Now suddenly, just 2 weeks after allowing the exports to resume the government wishes us to stop manufacturing or hold stocks for 2 months,” he rued.

“The high-volume high-speed production lines can’t switch overnight from domestic market labelling to export labelling and international buyers preferred specifications,” Nath said.

He also said that there should be better supply chain management and the Centre needs to be a “fair buyer”.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Feb 17, 2022 06:18 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347